Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-466-0 | CAS number: 141-18-4
Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- disregarded due to major methodological deficiencies
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: The data were based on secondary source (MSDS, ChemID, RTECS. Primary source (Industrial Hygiene and Toxicology, 2nd ed., Patty, F.A., ed., New York, John Wiley & Sons, Inc., 1958-63Vol. 2, Pg. 1882, 1963) could not be retrieved.
Data source
Referenceopen allclose all
- Reference Type:
- secondary source
- Title:
- Unnamed
- Reference Type:
- secondary source
- Title:
- No information
- Author:
- ChemID
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Bis(2-butoxyethyl) adipate
- EC Number:
- 205-466-0
- EC Name:
- Bis(2-butoxyethyl) adipate
- Cas Number:
- 141-18-4
- Molecular formula:
- C18H34O6
- IUPAC Name:
- 1,6-bis(2-butoxyethyl) hexanedioate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
Results and discussion
Effect levels
- Dose descriptor:
- LD50
- Effect level:
- 600 mg/kg bw
- Remarks on result:
- other: intraperitoneal
Applicant's summary and conclusion
- Conclusions:
- LD50 after intraperitoneal administration in rats was 600 mg/kg bw.
- Executive summary:
LD50 was reported to be 600 mg/kg bw after intraperitoneal administration in rats. This information was based on secondary source; no further information could be retrieved from primary sources.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
